Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Victory Square Technologies Inc C.VST

Alternate Symbol(s):  VSQTF

Victory Square Technologies Inc. is a Canada-based venture builder that provides investors a liquid way to invest in early-stage technology companies without buying a venture fund that requires accredited investor status or multi-year commitments. The Company has a diverse portfolio of approximately 25+ companies that are engaged in verticals, including artificial intelligence (AI), machine learning (ML), blockchain/Web3, virtual and augmented reality (VR/AR), gaming, climate tech, creator economy, digital health, and others. The Company is committed to organizations that provide services in the youth, mental health, special needs, sport, tech, education, marginalized groups, first nations, and accessibility sectors. The Company’s subsidiaries include VS Digital Health Inc., Hydreight Canada Holdings Inc., IV Hydreight Inc., Hydreight Technologies Inc., Futura Health & Wellness Inc., Draft Label Technologies Inc., XR Immersive Tech Inc. and others.


CSE:VST - Post by User

Post by 6ixs7eV3nsRocon Sep 18, 2020 2:13pm
140 Views
Post# 31582374

Victory Square and future catalysts

Victory Square and future catalystsRapid 5-15min Antibody test 93.3% sensitivity and 98.7% specificity based on real human trials. Unique low cost2-in-1 test for active AND previous infection FDA EUA Approval Brazil ANVISA Approval EU CE Approval Only test approved through Sao Paolo Government Ideiagov program Increased Brazil manufacturing capacity of 5MM bringing total to 6-7MM / month EPS of .7, portfolio of 20+ companies that are reaching maturity. Catalysts: Health Canada Approval India Approval Full FDA Approval NDAs becoming definitive agreements Preorders becoming definitive agreements Increased manufacturing capacity Acquisition of accredited productions labs 360 Healthcare platform to compliment test
Bullboard Posts